Literature DB >> 24857769

Assessing speech dysfunction using BOLD and acoustic analysis in parkinsonism.

Mohit Saxena1, Madhuri Behari1, S Senthil Kumaran2, Vinay Goyal1, Vaishna Narang3.   

Abstract

INTRODUCTION: Speech dysfunction is often associated with parkinsonism (Parkinson's disease (PD), Multiple System Atrophy (MSA), and Progressive Supranuclear Palsy (PSP)), along with characteristic motor features. Any or all of the following i.e. respiratory, phonatory, resonatory, or articulatory components of speech production may be affected. Articulatory imprecision, repetition of syllables (tachyphrenia), and tremor of oropharyngeal structures add to speech unintelligibility. We studied acoustics using spectrogram and its correlation with BOLD activation during voice/speech production across these subjects.
METHODS: BOLD studies were conducted on 108 subjects (29 PD, 20 MSA and 19 PSP and 40 controls) on 1.5 T MR scanner using 130 dynamics. Active phase involved acquisition (10 volumes each) of audible reading of visually presented bi-syllabic meaningful Hindi simple words (5 types of non-nasal stop consonant categories, i.e. namely velars, palatals, retroflexes, dentals, bilabials and one nasal stop consonant) with interleaved silence during baseline. The subjects' voice samples were analyzed for acoustic parameters, namely formant frequencies of the adjoining vowels, voice onset time (VOT), and intensities using spectrogram. Correlation of BOLD activation in different brain areas with acoustic parameters was evaluated.
RESULTS: Voice intensity was significantly lowered, while VOTs were delayed in these patients as compared to healthy controls. All acoustic parameters were significantly affected for nasal consonants. BOLD activation correlated positively in primary motor cortex to VOTs, while F2 formants to activation of supplementary motor area.
CONCLUSION: The differences in the acoustic quality of various stop consonants in patients may be helpful in differentiating these three parkinsonian disorders.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Articulation; BOLD; Multiple system atrophy; Parkinson's disease; Progressive supranuclear palsy

Mesh:

Year:  2014        PMID: 24857769     DOI: 10.1016/j.parkreldis.2014.04.024

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  7 in total

Review 1.  Speech disorders in Parkinson's disease: early diagnostics and effects of medication and brain stimulation.

Authors:  L Brabenec; J Mekyska; Z Galaz; Irena Rektorova
Journal:  J Neural Transm (Vienna)       Date:  2017-01-18       Impact factor: 3.575

2.  Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.

Authors:  Jan Rusz; Cecilia Bonnet; Jiří Klempíř; Tereza Tykalová; Eva Baborová; Michal Novotný; Aaron Rulseh; Evžen Růžička
Journal:  J Neurol       Date:  2015-02-17       Impact factor: 4.849

Review 3.  Therapy-resistant symptoms in Parkinson's disease.

Authors:  Ruxandra Julia Vorovenci; Roberta Biundo; Angelo Antonini
Journal:  J Neural Transm (Vienna)       Date:  2015-09-26       Impact factor: 3.575

4.  Evidence for early and progressive ultrasonic vocalization and oromotor deficits in a PINK1 gene knockout rat model of Parkinson's disease.

Authors:  Laura M Grant; Cynthia A Kelm-Nelson; Breanna L Hilby; Katherine V Blue; Eunice S Paul Rajamanickam; Joshua D Pultorak; Shelia M Fleming; Michelle R Ciucci
Journal:  J Neurosci Res       Date:  2015-07-31       Impact factor: 4.164

5.  Distinctive speech signature in cerebellar and parkinsonian subtypes of multiple system atrophy.

Authors:  Jan Rusz; Tereza Tykalová; Giulio Salerno; Serena Bancone; Johara Scarpelli; Maria Teresa Pellecchia
Journal:  J Neurol       Date:  2019-03-11       Impact factor: 4.849

6.  Mapping typical and hypokinetic dysarthric speech production network using a connected speech paradigm in functional MRI.

Authors:  Shalini Narayana; Megan B Parsons; Wei Zhang; Crystal Franklin; Katherine Schiller; Asim F Choudhri; Peter T Fox; Mark S LeDoux; Michael Cannito
Journal:  Neuroimage Clin       Date:  2020-06-01       Impact factor: 4.881

7.  Immediate and long-term effects of speech treatment targets and intensive dosage on Parkinson's disease dysphonia and the speech motor network: Randomized controlled trial.

Authors:  Shalini Narayana; Crystal Franklin; Elizabeth Peterson; Eric J Hunter; Donald A Robin; Angela Halpern; Jennifer Spielman; Peter T Fox; Lorraine O Ramig
Journal:  Hum Brain Mapp       Date:  2022-02-10       Impact factor: 5.038

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.